WS #10695
The dominant signal in this window is the escalation of the Strait of Hormuz crisis, with the UN's shipping agency temporarily pausing its evacuation plan for stranded ships after a vessel was attacked in the Gulf of Oman. This follows a prior ship strike in the Strait of Hormuz, confirming a deteriorating security situation that threatens oil transit chokepoints. The UN agency clarified the attacked ship did not transit under its evacuation framework, suggesting the attack was deliberate and outside normal protocols. This development escalates the geopolitical risk premium for oil and shipping, countering the prior narrative of potential de-escalation. Separately, the Venezuela earthquake death toll has risen to 188 with 1,520 injured, adding to idiosyncratic risk in the region. On the corporate front, Microsoft's Xbox price hikes (Series S 1TB to $599, Series X to $800) due to component cost inflation corroborate the tech margin compression theme, with Microsoft stock hitting a 52-week low. However, Micron continues to provide a bullish counter-signal for semiconductors, with Goldman Sachs raising its price target to $1100 (from $900) and maintaining Neutral, while SK Hynix surged 12%. The Supreme Court's 7-2 ruling in favor of Bayer in the Roundup cancer lawsuit is a significant legal victory, blocking thousands of failure-to-warn claims and sending Bayer shares up nearly 18%, which could impact the agrochemical sector and related litigation plays. The US-Uzbekistan trade deal signals potential tariff relief for industrial and agricultural goods, but is low significance for US markets. The narrative arc is one of escalating geopolitical risk in the Middle East (Hormuz) and persistent tech margin compression, partially offset by strong semiconductor earnings and a major legal win for Bayer.
Topics
Key developments
- UN pauses Hormuz evacuation plan after ship attack in Gulf of Oman
- Microsoft raises Xbox prices, stock hits 52-week low amid regulatory probes
- Goldman Sachs raises Micron price target to $1100, maintains Neutral
- Supreme Court rules in favor of Bayer in Roundup cancer lawsuit, shares jump 18%
- Venezuela earthquake death toll rises to 188, 1,520 injured